Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

15.45
Delayed Data
As of Dec 02
 -0.35 / -2.22%
Today’s Change
9.59
Today|||52-Week Range
18.75
-10.64%
Year-to-Date
Heat Biologics Stock Falls on Negative Bladder Cancer Data
Dec 01 / Zacks.com - Paid Partner Content
Sucampo (SCMP) Worth a Look: Stock Jumps 6.2% in Session
Nov 30 / Zacks.com - Paid Partner Content
Achaogen (AKAO) Catches Eye: Stock Adds 6.5% in Session
Dec 01 / Zacks.com - Paid Partner Content
This Value Screen Is Our Top Performer This Year
Nov 29 / Zacks.com - Paid Partner Content
Cytori Scleroderma Study Two-Year Follow-Up Data Published
Nov 30 / Zacks.com - Paid Partner Content
The Pockets of Speculative Action Have Dried Up
Nov 29 / TheStreet.com - Paid Partner Content
PhaseRx Soars on Orphan Drug Status for Rare Liver Disease
Nov 30 / Zacks.com - Paid Partner Content
Nivalis (NVLS) Cystic Fibrosis Study Misses Primary Endpoint
Nov 29 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Chimera Investment, PennyMac Financial Services and Su...
Nov 30 / Zacks.com - Paid Partner Content
Recro Pharma (REPH) in Focus: Stock Moves 19.8% Higher
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.80
Today’s open15.80
Day’s range15.35 - 16.05
Volume587,072
Average volume (3 months)382,677
Market cap$708.2M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+151.72%
Earnings growth (this year)+25.72%
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)+32.68%
P/E ratio53.3
Price/Sales5.16
Price/Book8.13

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-0.10-0.52%
ADROAduro Biotech Inc+0.25+2.37%
CLCDCoLucid Pharmaceutic...+2.30+6.35%
ACRSAclaris Therapeutics...+0.46+1.59%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)$0.47
Annual revenue (last year)$153.2M
Annual profit (last year)$33.4M
Net profit margin21.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs